Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S McCune

Showing results (111-120 of 174) with videos related to

Pageof 18
Sort By:
Pediatric Blood & Cancer|October 9, 2012
Glucocorticoids and insulin resistance in children with acute lymphoblastic leukemiaEric J Chow, Catherine Pihoker, Debra L Friedman, et al.
Cancer Chemotherapy and Pharmacology|April 10, 2008
A novel phenotypic method to determine fludarabine triphosphate accumulation in T-lymphocytes from hematopoietic cell transplantation patientsErica L Woodahl, Joanne Wang, Shelly Heimfeld, et al.
Clinical Pharmacology and Therapeutics|March 20, 2009
Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancyJ S McCune, A Batchelder, K A Guthrie, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 23, 2018
Identification of Intestinal UDP-Glucuronosyltransferase Inhibitors in Green Tea (<i>Camellia sinensis)</i> Using a Biochemometric Approach: Application to Raloxifene as a Test Drug via In Vitro to In Vivo ExtrapolationDan-Dan Tian, Joshua J Kellogg, Neşe Okut, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 9, 2011
Accurate targeting of daily intravenous busulfan with 8-hour blood sampling in hospitalized adult hematopoietic cell transplant recipientsRosa F Yeh, Matthew A Pawlikowski, David K Blough, et al.
Clinical and Translational Science|November 3, 2025
Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Analysis for Clazakizumab in Patients With End-Stage Kidney Disease Undergoing DialysisVenkateswari Y Muthukrishnan, Thomas Kerbusch, Laura E Strong, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
Catalyzing the Critical Path Initiative: FDA's progress in drug development activitiesA Parekh, S Buckman-Garner, S McCune, et al.
Journal of Clinical Pharmacology|February 28, 2013
Variation in prescribing patterns and therapeutic drug monitoring of intravenous busulfan in pediatric hematopoietic cell transplant recipientsJeannine S McCune, K Scott Baker, David K Blough, et al.
Journal of Biological Response Modifiers|December 1, 1986
Specific immunotherapy with suppressor function inhibition for metastatic renal cell carcinomaD M Sahasrabudhe, J B deKernion, J E Pontes, et al.
The Pharmacogenomics Journal|August 19, 2007
Pharmacogenomic associations in ABCB1 and CYP3A5 with acute kidney injury and chronic kidney disease after myeloablative hematopoietic cell transplantationE L Woodahl, S R Hingorani, J Wang, et al.
Pageof 18

Showing results (111-120 of 174) with videos related to

Sort By:
Pageof 18
Pediatric Blood & Cancer|October 9, 2012
Glucocorticoids and insulin resistance in children with acute lymphoblastic leukemiaEric J Chow, Catherine Pihoker, Debra L Friedman, et al.
Cancer Chemotherapy and Pharmacology|April 10, 2008
A novel phenotypic method to determine fludarabine triphosphate accumulation in T-lymphocytes from hematopoietic cell transplantation patientsErica L Woodahl, Joanne Wang, Shelly Heimfeld, et al.
Clinical Pharmacology and Therapeutics|March 20, 2009
Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancyJ S McCune, A Batchelder, K A Guthrie, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 23, 2018
Identification of Intestinal UDP-Glucuronosyltransferase Inhibitors in Green Tea (<i>Camellia sinensis)</i> Using a Biochemometric Approach: Application to Raloxifene as a Test Drug via In Vitro to In Vivo ExtrapolationDan-Dan Tian, Joshua J Kellogg, Neşe Okut, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 9, 2011
Accurate targeting of daily intravenous busulfan with 8-hour blood sampling in hospitalized adult hematopoietic cell transplant recipientsRosa F Yeh, Matthew A Pawlikowski, David K Blough, et al.
Clinical and Translational Science|November 3, 2025
Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Analysis for Clazakizumab in Patients With End-Stage Kidney Disease Undergoing DialysisVenkateswari Y Muthukrishnan, Thomas Kerbusch, Laura E Strong, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
Catalyzing the Critical Path Initiative: FDA's progress in drug development activitiesA Parekh, S Buckman-Garner, S McCune, et al.
Journal of Clinical Pharmacology|February 28, 2013
Variation in prescribing patterns and therapeutic drug monitoring of intravenous busulfan in pediatric hematopoietic cell transplant recipientsJeannine S McCune, K Scott Baker, David K Blough, et al.
Journal of Biological Response Modifiers|December 1, 1986
Specific immunotherapy with suppressor function inhibition for metastatic renal cell carcinomaD M Sahasrabudhe, J B deKernion, J E Pontes, et al.
The Pharmacogenomics Journal|August 19, 2007
Pharmacogenomic associations in ABCB1 and CYP3A5 with acute kidney injury and chronic kidney disease after myeloablative hematopoietic cell transplantationE L Woodahl, S R Hingorani, J Wang, et al.
Pageof 18